Back
Aclaris Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
ACRS
Aclaris Therapeutics, Inc.
Last Price:
$3.16
Seasonality Move:
26.08%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACRS is experiencing slight selling pressure.
Aclaris Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.41 | Sell |
| 20-day SMA: | 3.64 | Sell |
| 50-day SMA: | 3.26 | Sell |
| 200-day SMA: | 2.17 | Buy |
| 8-day EMA: | 3.35 | Sell |
| 20-day EMA: | 3.41 | Sell |
| 50-day EMA: | 3.21 | Sell |
| 200-day EMA: | 2.49 | Buy |
Aclaris Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 44.42 | Sell |
| Chaikin Money Flow: | -288435 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.99 - 4.05) | Sell |
| Bollinger Bands (100): | (2.08 - 3.4) | Buy |
Aclaris Therapeutics, Inc. Technical Analysis
| Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aclaris Therapeutics, Inc. Stock
Is Aclaris Therapeutics, Inc. Stock a Buy?
-
Aclaris Therapeutics, Inc. share price is 3.17 while ACRS 8-day simple moving average is 3.41, which is a Sell signal.
-
The stock price of ACRS is 3.17 while Aclaris Therapeutics, Inc. 20-day SMA is 3.64, which makes it a Sell.
-
Aclaris Therapeutics, Inc. 50-day simple moving average is 3.26 while ACRS share price is 3.17, making it a Sell technically.
-
ACRS stock price is 3.17 and Aclaris Therapeutics, Inc. 200-day simple moving average is 2.17, creating a Buy signal.
ACRS Technical Analysis vs Fundamental Analysis
Sell
46
Aclaris Therapeutics, Inc. (ACRS)
is a Sell
Is Aclaris Therapeutics, Inc. a Buy or a Sell?
-
Aclaris Therapeutics, Inc. stock is rated a SellThe current Aclaris Therapeutics, Inc. [ACRS] share price is $3.17. The Score for ACRS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Aclaris Therapeutics, Inc. Stock Info
Market Cap:
343.5M
Price in USD:
3.17
Share Volume:
980.7K
Aclaris Therapeutics, Inc. 52-Week Range
52-Week High:
4.89
52-Week Low:
1.05
Sell
46
Aclaris Therapeutics, Inc. (ACRS)
is a Sell
Aclaris Therapeutics, Inc. Share Price Forecast
-
What is the Aclaris Therapeutics, Inc. stock price today?The Aclaris Therapeutics, Inc. stock price is 3.17 USD today.
-
Will ACRS stock go up or go down?Aclaris Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Aclaris Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics, Inc. is overvalued.
Is Aclaris Therapeutics, Inc. Stock a Buy?
-
Aclaris Therapeutics, Inc. share price is 3.17 while ACRS 8-day exponential moving average is 3.35, which is a Sell signal.
-
The stock price of ACRS is 3.17 while Aclaris Therapeutics, Inc. 20-day EMA is 3.41, which makes it a Sell.
-
Aclaris Therapeutics, Inc. 50-day exponential moving average is 3.21 while ACRS share price is 3.17, making it a Sell technically.
-
ACRS stock price is 3.17 and Aclaris Therapeutics, Inc. 200-day simple moving average is 2.49, creating a Buy signal.
Fundamental Analysis of Aclaris Therapeutics, Inc.
Is Aclaris Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.22 per share.
Technical Analysis of Aclaris Therapeutics, Inc.
Should I short Aclaris Therapeutics, Inc. stock?
-
ACRS Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Aclaris Therapeutics, Inc. is a Buy
-
Aclaris Therapeutics, Inc. Relative Strength Index (RSI) is 44.42, which suggest Aclaris Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Aclaris Therapeutics, Inc. is (2.99 - 4.05), which suggest Aclaris Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Aclaris Therapeutics, Inc. is (2.08 - 3.4), which suggest Aclaris Therapeutics, Inc. is a Buy
* Aclaris Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.